“…Moreover, H. pylori may be implicated in several extra-gastric diseases such as iron de ciency anemia, idiopathic thrombocytopenic purpura, and several dermatological disorders (Chmiela et al, 2017, Kodaman et al, 2014, Testerman and Morris, 2014. Its distribution is worldwide and affects more than 90% of the world population, but it is more common in developing countries with the highest prevalence found in Africa (Idris et al, 2021, Zamani et al, 2018, probably due to the possible transmission through fecal-oral route and the unsafe sanitation conditions in these countries (Eldeen et al, 2019, Nevoa et al, 2017.Clinically, a variety of various invasive techniques (requiring endoscopy and biopsy which include, culture, histological examination, and rapid urease test, CLO (Campylobacter like organism) test, smear examination, and molecular studies) or noninvasive techniques (including serology, respiratory urea breath test, or the detection of fecal antigen) are often performed to detect H. pylori infection (Akanda and Rahman, 2011, Mawlood et al, 2019, Wang et al, 2015. The sensitivity of any of those techniques in detecting H. pylori relays on how the density of the bacterial cells within the specimens taken by biopsy (recent use of disease related medications speci cally antibiotics and proton-pump inhibitors can reduce the density of the cells), pathologist expertise, also the type and quality of the stain used for detection purposes (Mawlood et al, 2019).…”